Approval · Notice of Compliance 8083 · 2006
ORENCIA: Notice of Compliance 8083
Issued June 29, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8083
- Date
- June 29, 2006
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Selective co-stimulation modulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORENCIA | 02282097 | Marketed |
Medicinal ingredients
- ABATACEPT 250 MG per VIAL